Ballard Spahr Advises MGC Diagnostics Corporation in $50 Million Sale to Altus Capital Partners, Inc.
Ballard Spahr advised MGC Diagnostics Corporation (MGC) in its $50.3 million sale to private equity firm Altus Capital Partners, Inc. Minneapolis-based Business and Finance Partners Jonathan B. Levy and Thomas G. Lovett, IV led the legal team.
MGC is a global medical technology company focused on cardiorespiratory health solutions. The conclusion of the tender offer and subsequent cash-out merger for all outstanding shares of MGC's common stock effectively takes the company private and positions MGC for product innovation and growth.
Mr. Levy advises private and public companies—as well as officers, directors, and shareholders—on a range of corporate and securities law matters. He has significant experience in public company mergers and acquisitions and other change-in-control and strategic transactions. Mr. Lovett focuses on corporate and securities matters, including public and private offerings, mergers and acquisitions, corporate governance, general representation of SEC reporting companies, and the representation of investment bankers and broker-dealers.
Minneapolis-based associates Jamie S. Buskirk and Christian R. Barnes also advised MGC in this matter.